FORM 8-A
Securities and Exchange Commission
Washington, D.C. 20549
For registration of certain classes of securities
pursuant to section 12(b) or (g) of the
Securities Exchange Act of 1934
BIO-BRIDGE SCIENCE, INC.
------------------------
(Exact name of registrant as specified in its charter)
Delaware 20-1802936
-------- ----------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
1211 West 22nd Street, Suite 615, Oak Brook, Il. 60523
------------------------------------------------ -----
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act: None
Title of each class to be so Name of each exchange on which each class is
registered to be registered
-------------------- ----------------------------------
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box. [ ]
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box. [X]
Securities Act registration statement file number to which this form relates:
333-121786
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value per share
----------------------------------------
(Title of class)
Item 1. Description of Registrant's Securities to be Registered.
Bio-Bridge Science, Inc. (the "Registrant") hereby incorporates by reference the
description of its securities to be registered hereunder contained under the
heading "Description of Securities" in Registrant's Registration Statement on
Form SB-2 (File No.: 333-121786), as originally filed with the Securities and
Exchange Commission (the "Commission") on December 30, 2004 and subsequently
amended (the "Registration Statement"), and in the prospectus included in the
Registration Statement to be combined with the prospectus included in the
Registrant's Registration Statement on Form SB-2 (File No.: 333-127313), as
originally filed with the Commission on August 8, 2005, and filed separately by
Registrant with the Commission pursuant to Rule 424(b) under the Securities Act
of 1933, as amended.
Item 2. Exhibits.
The following exhibits are filed herewith or incorporated by reference herein as
indicated below:
Number Description
- ------ -----------
3.1(i)* Certificate of Incorporation of the Registrant, as currently in
effect
3.1(ii)* Bylaws of the Registrant, as currently in effect
10.3* 2004 Stock Incentive Plan
*Incorporated by reference to the identically numbered exhibit to the
Registrant's Registration Statement on Form SB-2 filed on December 30, 2004, as
amended (File No. 333-121786).
Signature
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Date: August 12, 2005
BIO-BRIDGE SCIENCE, INC.
a Delaware corporation
By: /s/ Dr. Liang Qiao
------------------------------
Dr. Liang Qiao,
Chief Executive Officer